An update from Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ) is now available.
ResMed Inc has filed a notice for the proposed sale of securities under Rule 144, with Brett Sandercock, an officer of the company, planning to sell 1,000 common shares. The transaction, scheduled for March 10, 2025, follows previous sales by Sandercock in January and February 2025, indicating a strategic move in managing personal holdings without any adverse information affecting the company’s operations.
More about Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
ResMed Inc operates in the healthcare industry, focusing on the development and manufacturing of equipment related to sleep disorders and respiratory care. The company is known for its innovative solutions in sleep apnea treatment and other respiratory conditions, positioning itself as a leader in this specialized market.
YTD Price Performance: -2.20%
Average Trading Volume: 1,056,972
Technical Sentiment Consensus Rating: Sell
Current Market Cap: A$54.31B
See more insights into RMD stock on TipRanks’ Stock Analysis page.